MakeMyTrip (NASDAQ:MMYT) 주식

MakeMyTrip

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

Indianapolis,-,Circa,November,2021:,Eli,Lilly,And,Company,World

Earnings

Equities

Large Cap

News

Movers

AFRM

ARGX

BNTX

DASH

MMYT

REGN

SMMT

VRTX

지난주 가장 저조한 성과를 기록한 대형주는 다음과 같다. 일라이 릴리, 어펌 홀딩스, 리제네론, 아겐스, 버텍스 파마슈티컬스, 서밋 테라퓨틱스, 메이크마이트립, 바이오엔테크, FNF, 오로라, 도어대시

일라이릴리·어펌홀딩스·리제네론 등 지난주 급락한 대형주 12종목 (5월 5일~9일)

Regenreon

Trading Ideas

FCNCA

KNTK

MEDP

SMCI

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 서밋 테라퓨틱스(NASDAQ:SMMT)의 주가는 씨티그룹이 주식을 매수에서 중립으로 하향 조정했으나 목표 주가를 19달러에서 23달러로 상향 조정한 후 14.37% 하락했다.

리제네론과 슈퍼 마이크로는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 23일-9월 27일)

MakeMyTrip Ltd

U.S. stocks were higher, with the Dow Jones index gaining around 450 points on Tuesday.
Shares of Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) rose sharply during Tuesday's session after the company reported <a href="https://www.benzinga.com/markets/earnings/25/06/46076919/carnival-sails-past-q2-estimates-raises-full-year-outlook-on-strong-demand">better-than-expected second-quarter EPS and sales.</a>
The global cruise company reported adjusted earnings per share of 35 cents, beating the analyst consensus estimate of 24 cents. Quarterly sales of $6.328 billion outpaced the Street view of $6.207 billion.
Carnival shares jumped 9.3% to $352.11 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares jumped 28.5% to $25.72 after the company announced it will be acquired by C&amp;S Wholesale Grocers.</li>
<li>Rezolve AI PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) gained 27% to $2.5865. Rezolve AI recently announced it will join the Russell 2000 and Russell 3000 indexes</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) gained 21.2% to $12.59.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) rose 18.4% to $4.95.</li>
<li>Ambarella, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) surged 17.4% to $60.56.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) climbed 14.4% to $13.01.</li>
<li>Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) gained 14% to $23.25 after the company entered into a definitive agreement to acquire technology solution providers CNS and CANS in Thailand.</li>
<li>CommScope Holding Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COMM#NASDAQ">COMM</a>) rose 13.8% to $7.35. Deutsche Bank analyst Matthew Niknam maintained CommScope with a Hold and raised the price target from $6 to $7.5.</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) gained 13.5% to $55.66.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) surged 13.3% to $9.48.</li>
<li>Amylyx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) rose 13.2% to $5.68. Guggenheim analyst Seamus Fernandez initiated coverage on Amylyx Pharmaceuticals with a Buy rating and announced a price target of $17.</li>
<li>NextDecade Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXT#NASDAQ">NEXT</a>) gained 12.5% to $9.26.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) surged 12.1% to $89.36.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) gained 12% to $164.54. Avis Budget Group announced the appointment of Daniel Cunha as Chief Financial Officer.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) rose 10% to $18.06.</li>
<li>Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) gained 9.3% to $16.80. HC Wainwright &amp; Co. analyst Scott Buck reiterated Redwire with a Buy and maintained a $26 price target.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) rose 9.1% to $335.50. Shares of crypto-linked stocks and miners traded higher amid a rise in Bitcoin.</li>
<li>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) gained 7.7% to $91.81 after the company announced that it began offering autonomous ride options with Waymo in Atlanta.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) rose 6.8% to $97.72. Macquarie analyst Aditya Suresh upgraded MakeMyTrip from Neutral to Outperform and announced a $110 price target.</li>
<li>Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) gained 6.1% to $80.99.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

AMBA

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

BBAI

COIN

COMM

New Oriental Education & Technology Group

GRRR

HOOD

LIMN

MBLY

OCUL

PONY

RZLV

UBER

Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Macquarie analyst Aditya Suresh upgraded the rating for MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) from Neutral to Outperform and announced a $110 price target. MakeMyTrip shares closed at $91.51 on Monday. <a href="https://www.benzinga.com/quote/mmyt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst DS Kim upgraded New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) from Neutral to Overweight and raised the price target from $48 to $62. New Oriental Education shares closed at $49.05 on Tuesday. <a href="https://www.benzinga.com/quote/edu/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. analyst Sudan Loganathan upgraded Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) from Equal-Weight to Overweight and raised the price target from $29 to $60. Exelixis shares closed at $43.37 on Tuesday. <a href="https://www.benzinga.com/quote/exel/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying MMYT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/MMYT/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="581" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24083222/image-359-1024x581.png" alt="" class="wp-image-959797" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24083222/image-359-1024x581.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24083222/image-359-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24083222/image-359-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24083222/image-359.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Upgrades

Analyst Ratings

CRDF

EXEL

GLXY

This MakeMyTrip Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday

Macquarie analyst Aditya Suresh upgrades MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) from Neutral to Outperform and announces $110 price target.

Price Target

Macquarie Upgrades MakeMyTrip to Outperform, Announces $110 Price Target

MakeMyTrip Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>, the "Company" or "MakeMyTrip")), the "Company" or "MakeMyTrip"), today announced the upsize and pricing of its previously announced underwritten registered public offering (the "Primary Equity Offering") of ordinary shares of the Company, par value US$0.0005 per share (the "Primary Shares"). The size of the offering increased from the previously announced offering of 14,000,000 ordinary shares to 16,000,000 ordinary shares, at an offering price of US$90 per ordinary share. The underwriters have been granted a 13-day option to purchase up to 2,400,000 additional ordinary shares. The Primary Equity Offering is expected to close on June 23, 2025, subject to customary closing conditions.
The Company also announced today by separate press release the pricing of an offering of 0.00% convertible senior notes in an aggregate principal amount of US$1.25 billion due 2030 (the "Notes Offering") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company has granted the initial purchasers in the Notes Offering an option to purchase up to an additional US$187.5 million in aggregate principal amount of the Notes, exercisable for settlement within a 13-day period, beginning on, and including, the first date on which the Notes are issued.
MakeMyTrip estimates that the net proceeds from the Primary Equity Offering will be approximately US$1.41 billion, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by the Company (or approximately US$1.62 billion if underwriters exercise in full their option to purchase additional ordinary shares). The Company plans to use all of the net proceeds from the Primary Equity Offering and the Notes Offering for the Repurchase (as described below) of a portion of the Class B shares of the Company from Trip.com Group Limited ("Trip.com").
Repurchase
MakeMyTrip plans to use all of the net proceeds from the Primary Equity Offering and the Notes Offering to repurchase a portion of its Class B shares from Trip.com at a price per Class B share based on the offering price per ordinary share in the Primary Equity Offering after deducting underwriting discounts and commissions per ordinary share in the Primary Equity Offering (such transaction, the "Repurchase"). The Repurchase will be made pursuant to the Share Repurchase Agreement entered into on June 16, 2025 between MakeMyTrip and Trip.com.

Offerings

MakeMyTrip Upsizes Offering to 16M Shares (From Prior 14M) at $90 Each, Plans $1.25B Bond Sale To Buy Back Stock From Trip.com

WIIM

MakeMyTrip shares are trading lower after the company announced a proposed offering of 14 million ordinary shares and $1.25 billion in convertible noes.

U.S. stock futures were lower this morning, with the Dow futures falling more than 200 points on Tuesday.
Shares of Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) fell sharply in today's pre-market trading after the company <a href="https://www.benzinga.com/quote/RDW">announced a $200 million common stock offering.</a>
Redwire shares dipped 10.1% to $18.48 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares tumbled 27.4% to $7.00 in pre-market trading. Jefferies, last week, downgraded the stock from Hold to Underperform and lowered its price target from $6 to $5.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) dipped 21.5% to $18.79 in pre-market trading. Barclays analyst Christine Cho, last week, maintained SolarEdge Technologies with an Underweight and raised the price target from $11 to $12.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) declined 16.7% to $38.28 in pre-market trading.</li>
<li>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) declined 10.1% to $157.00 in pre-market trading. Jefferies analyst Julien Dumoulin-Smith, last week, upgraded First Solar from Hold to Buy and raised the price target from $157 to $192.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) fell 9.2% to $7.23 in pre-market trading.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) declined 8.6% to $12.80 in pre-market trading after dipping 13% on Monday.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) dipped 7.1% to $93.68 in pre-market trading as the company announced a proposed primary offering of ordinary shares.</li>
<li>Nextracker Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) dropped 6.7% to $56.67 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45966402/jabil-lennar-and-3-stocks-to-watch-heading-into-tuesday">Jabil, Lennar And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

ARRY

ENPH

FSLR

LZMH

SEDG

Redwire, MakeMyTrip And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

MakeMyTrip plans to use the entire net proceeds from the Primary Equity Offering and the Notes Offering for the Repurchase (as described below) of a portion of the Class B shares of the Company from Trip.com Group Limited ("Trip.com").

TCOM

Reported Earlier, MakeMyTrip Launches Proposed Offering Of 14M Ordinary Shares And $1.25B In Convertible Notes To Fund Repurchase From Trip.Com

MakeMyTrip Files For Offering Of 14M  Ordinary Shares

MakeMyTrip Files For Stock Shelf; Size Not Disclosed

Citigroup analyst Vijit Jain maintains MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) with a Buy and raises the price target from $120 to $125.

Citigroup Maintains Buy on MakeMyTrip, Raises Price Target to $125

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of 21 cents per share on sales of $17.25 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Sony shares fell 0.6% to $24.40 in after-hours trading.</li>
<li>American Eagle Outfitters Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) reported preliminary results for the first quarter and withdrew its full-year guidance. After the market close on Tuesday, American Eagle said in a filing that it expects to report first-quarter revenue of $1.1 billion, representing a decline of 5% year-over-year. American Eagle shares dipped 13.5% to $11.00 in the after-hours trading session.</li>
<li>Analysts are expecting Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) to post quarterly earnings at 92 cents per share on revenue of $14.05 billion. The company will release earnings after the markets close. Cisco shares gained 0.2% to $61.91 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>Alcon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) posted downbeat results for the first quarter on Tuesday. The company lowered its FY2025 earnings guidance, but raised its sales guidance. Alcon shares fell 2.4% to $91.00 in the after-hours trading.</li>
<li>Analysts expect MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) to report quarterly earnings at 30 cents per share on revenue of $255.93 million before the opening bell. MakeMyTrip shares rose 0.2% to $106.75 in after-hours trading.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

CSCO

Sony Group Corporation American Depositary Shares

SONY

American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Tuesday.
U.S. stocks settled mixed on Tuesday, with the Nasdaq Composite jumping around 300 points during the session. The U.S. and China agreed to a 90-day truce by slashing triple-digit tariffs effective May 14.
The Consumer Price Index showed signs of cooling in April, as both headline and core readings eased or met expectations, easing concerns that Trump&#8217;s proposed trade tariffs would trigger a surge in inflation.
Shares of NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped around 5.6% on Tuesday as the company announced a strategic partnership with HUMAIN aimed at establishing Saudi Arabia as a leader in artificial intelligence (AI) and GPU cloud computing. UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares tumbled around 18% after the company announced it suspended its FY25 guidance and announced the appointment of Stephen Hemsley as CEO.
Most sectors on the S&amp;P 500 closed on a negative note, with health care, consumer staples and real estate stocks recording biggest losses on Tuesday. However, information technology and consumer discretionary stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 270 points to 42,140.43 on Tuesday. The S&amp;P 500 surged 0.72% to 5,886.55, while the Nasdaq Composite jumped 1.61% at 19,010.08 during Tuesday's session.
Investors are awaiting earnings results from Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>), Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) and MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) today.
At a current reading of 68.7, the index remained in the &#8220;Greed&#8221; zone on Tuesday, versus a prior reading of 66.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

NVDA

Nasdaq Rises 300 Points Amid Surge In Nvidia Shares; Investor Sentiment Improves, Fear & Greed Index Remains In 'Greed' Zone

MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.30 by 40 percent. This is a 10.53 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $261.19 million which beat the analyst consensus estimate of $255.93 million by 2.06 percent. This is a 22.90 percent increase over sales of $212.53 million the same period last year.

Earnings Beats

MakeMyTrip Q4 Adj. EPS $0.42 Beats $0.30 Estimate, Sales $261.19M Beat $255.93M Estimate

ADCT

AEVA

AFCG

ALUR

ARCO

ATER

AYTU

BCDA

BITF

BNGO

The Beachbody Company, Inc. Class A Common Stock

BODI

BOOT

BRTX

BZAI

CAAS

CANG

CCAP

CDXS

CELC

CLBT

CLSD

CREX

CSPI

CSWC

CTSO

DAVA

DERM

DRIO

DYAI

EGAN

ELVA

EPSN

EWCZ

FIHL

FOSL

GCTS

GLBE

GROV

GWRS

HWKN

IBTA

ICCC

INVZ

IREN

ISSC

ITRG

JACK

KARO

KITT

KMDA

KRNT

LAZR

LDTC

LIEN

LIQT

LOCL

LUCD

LUXE

LVLU

MDXH

MGRM

NEXN

NSYS

NTWK

NVGS

NYXH

ONCY

PDSB

PYPD

RCAT

RDCM

REKR

RELI

RSKD

SBLK

SCPH

SDHC

SDOT

SDST

SGML

SHIM

Earnings Scheduled For May 14, 2025

ABNB

APEI

BGFV

CENN

CNTY

CTNT

CVNA

JZXN

NWTN

PRTS

SFIX

TSLA

Shares of companies within the broader consumer discretionary sector are trading higher amid overall market strength following softer-than-expected April inflation readings. Additionally, investors continue to weigh US-China trade progress and President Trump's Middle East trip.

MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) will release its quarterly earnings report on Wednesday, 2025-05-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate MakeMyTrip to report an earnings per share (EPS) of $0.43.
Anticipation surrounds MakeMyTrip's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.02, leading to a 0.34% drop in the share price the following trading session.
Here's a look at MakeMyTrip's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.26</td>
<td>0.28</td>
<td>0.20</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.39</td>
<td>0.36</td>
<td>0.39</td>
<td>0.38</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>5.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747148463_0.png" alt="eps graph" />
<h3>MakeMyTrip Share Price Analysis</h3>
Shares of MakeMyTrip were trading at $103.73 as of May 12. Over the last 52-week period, shares are up 24.73%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MMYT/earnings">To track all earnings releases for MakeMyTrip visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look at MakeMyTrip's Upcoming Earnings Report

ALGT

EXPE

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

NCLH

PLAY

ULCC

WYNN

Shares of travel and leisure stocks are trading higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. This could reduce economic uncertainty that has been clouding travel and spending outlook.

These large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol class="wp-block-list">
<li>argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) shares tumbled 15.40% after the <a href="https://www.benzinga.com//node/45275849" target="_blank" rel="noreferrer noopener">company reported first-quarter results</a>.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) shares dipped 15.20% after it reported lower-than-expected first-quarter 2025 earnings, and analysts <a href="https://www.benzinga.com//node/45236530" target="_blank" rel="noreferrer noopener">revised the price forecasts</a>.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) stock fell 14.12%.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) shares dived 12.96%.</li>
<li>Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) shares fell 12.85%. The U.S. Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended <a href="https://www.benzinga.com//node/45234032" target="_blank" rel="noreferrer noopener">for American consumers and patients</a>.</li>
<li>Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) shares dived 11.97% after reporting <a href="https://www.benzinga.com//node/45299460" target="_blank" rel="noreferrer noopener">first-quarter results</a>, but issuing a weaker-than-expected Q2 sales outlook.</li>
<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) stock was down 11.60% after the <a href="https://www.benzinga.com//node/45205736" target="_blank" rel="noreferrer noopener">company reported quarterly results</a>. Analysts revised the price <a href="https://www.benzinga.com/quote/bntx/analyst-ratings" target="_blank" rel="noreferrer noopener">forecast on the stock</a>.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) stock declined 11.33% after the company reported third-quarter results and <a href="https://www.benzinga.com//node/45322588" target="_blank" rel="noreferrer noopener">analysts revised the price forecast</a>.</li>
<li>FNF Group of Fidelity National Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) stock declined 10.98% after the company <a href="https://www.benzinga.com//node/45266700" target="_blank" rel="noreferrer noopener">reported first-quarter results</a>.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) stock fell 10.81% last week in reaction to an executive order from the Trump administration to boost <a href="https://www.benzinga.com//node/45233995" target="_blank" rel="noreferrer noopener">domestic drug manufacturing</a>.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) stock declined 10.57% after the company reported its<a href="https://www.benzinga.com//node/45300096" target="_blank" rel="noreferrer noopener"> first-quarter financial results</a>. Analysts revised the stock&#8217;s price forecast.</li>
<li>DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) shares decreased 10.52% after announcing downbeat first-quarter sales, and <a href="https://www.benzinga.com//node/45264549" target="_blank" rel="noreferrer noopener">analysts revised the price forecast</a>.</li>
</ol>
Photo by Jonathan Weiss via Shutterstock

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?

AGAE

APTV

Shares of companies within the broader consumer discretionary sector are trading higher amid overall market strength following April's jobs data and reports that China's Commerce Ministry is assessing possible trade talks with the US.

Comments

MakeMyTrip

뉴스

파트너 / 기고자

벤징가 글로벌